SCHEMBL749869

SCHEMBL749869

[NH]CCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9478728 0.96 LMNA (0.44)
SCHEMBL6507209 0.96
SCHEMBL1289416 0.96
SCHEMBL9481388 0.96 LMNA (0.44)
SCHEMBL9478813 0.96 LMNA (0.44)
SCHEMBL460354 0.96
SCHEMBL359512 0.87
1,4-Butanediol SCHEMBL18642519 0.76 SMN1; SMN2 (0.58)
1,4-Butanediol SCHEMBL30932429 0.76
1,4-Butanediol SCHEMBL18642509 0.76 SMN1; SMN2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117126180-A Biphenyl compound as immunomodulator as well as preparation method and application thereof 深圳微芯生物科技股份有限公司 2023-11-28 CN claimed
EP-2303283-A2 ANTI-CANCER COMBINATION THERAPY Katholieke Universiteit Leuven K.U. Leuven R&D (BE) 2011-04-06 EP claimed
US-20110065663-A1 ANTI-CANCER COMBINATION THERAPY KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D 2011-03-17 US claimed
WO-2009138507-A2 ANTI-CANCER COMBINATION THERAPY KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2009-11-19 WO claimed
CN-101426792-A Pyrazolopyrimidines as therapeutic agents ABBOTT GMBH & CO KG (DE) 2009-05-06 CN claimed
EP-1330452-B1 PYRAZINE DERIVATIVES AS MODULATORS OF TYROSINE KINASES ORTHO MCNEIL PHARM INC (US) 2008-11-26 EP claimed
CN-1520298-A Pyrazolopyrimidines as therapeutic agents �����ʩ���عɷݹ�˾ 2004-08-11 CN claimed
US-6710048-B2 SELECTIVE INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE; TO TREAT SOLID-TUMOR CANCERS, ANGIOGENESIS, DIABETIC RETINOPATHY, RHEUMATOID ARTHRITIS, ENDOMETRIOSIS AND PSORIASIS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2004-03-23 US claimed
EP-1330452-A2 PYRAZINE DERIVATIVES AS MODULATORS OF TYROSINE KINASES Ortho-McNeil Pharmaceutical, Inc. (US) 2003-07-30 EP claimed
US-20030060629-A1 Pyrazine derivatives as modulators of tyrosine kinases ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-03-27 US claimed
US-6514977-B1 For treating p38 kinase mediated disorders G.D. SEARLE & COMPANY 2003-02-04 US claimed
WO-2002024681-A2 PYRAZINE DERIVATIVES AS MODULATORS OF TYROSINE KINASES ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2002-03-28 WO claimed
CN-1342157-A Substituted pyrazoles ASP38 kinase inhibitors SEARLE & CO (US) 2002-03-27 CN claimed
EP-0881268-A1 Fiber-reactive triphendioxazine dyes, process for their preparation and the use thereof DyStar Textilfarben GmbH &amp; Co. Deutschland KG (DE) 1998-12-02 EP claimed
US-5328902-A Antibiotics AMERICAN CYANAMID CO. (US) 1994-07-12 US claimed
EP-0200024-B1 3-CYANO-PYRIDINES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE ARZNEIMITTELWERK DRESDEN GmbH (DE) 1992-07-01 EP claimed
EP-0200024-A2 3-Cyano-pyridines, process for their preparation and their pharmaceutical use ARZNEIMITTELWERK DRESDEN GmbH (DE) 1986-11-05 EP claimed
EP-0006227-B1 ANTITHROMBOTIC PHARMACEUTICAL PREPARATION CONTAINING 2,2'-DITHIOBIS BENZAMIDE DERIVATIVES AND NEW 2,2'-DITHIOBIS BENZAMIDE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD (JP) 1984-12-27 EP claimed
CN-117126180-A Biphenyl compound as immunomodulator as well as preparation method and application thereof 深圳微芯生物科技股份有限公司 2023-11-28 CN disclosed
US-3998827-A HYPOTENSIVE AGENTS THE UPJOHN COMPANY (US) 1976-12-21 US disclosed